Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Cancer Res. 2008 Jun 1;68(11):4086–4096. doi: 10.1158/0008-5472.CAN-07-6458

Table 2.

MT1-MMP target genes

Accession Gene Ranking HT-MT/HT-siRNA
1 NM_004938 DAPK1 113 2.6
2 NM_182977 NNT 257 2.1
3 NM_005630 SLCO2A1 297 2.2
4 NM_000214 JAG1 444 2.0
5 NM_005026 PI3Kδ 585 2.3
6 NM_000176 NR3C1 640 2.1
7 NM_177560 CK2α 677 2.0
8 NM_139035 SMARCA1 684 3.7
9 NM_007271 STK38 810 2.0
10 NM_198220 SNRPB2 912 2.0
11 NM_001156 ANXA7 944 3.8

NOTE: Ranking of the genes corresponds to the Euclidean distance from the MT1-MMP reference gene, as shown in Supplementary Table S4 that includes approximately 16,000 genes. HT-MT/HT-siRNA, the ratio of gene expression levels in HT-MT cells versus HT-siRNA cells.

Abbreviations: ANXA7, annexin 7; CK2α, protein kinase 2 alpha; DAPK1, death-associated protein kinase 1; JAG1, Jagged 1; NR3C1, nuclear glucocorticoid receptor; NNT, nicotinamide nucleotide transhydrogenase; PI3Kδ, phosphoinositide-3-kinase delta; SLCO2A1, solute carrier organic anion transporter; SMARCA1, actin dependent regulator of chromatin; SNRPB2, small nuclear ribonucleoprotein polypeptide B'; STK38/NDR1, serine-threonine kinase 38/N-myc downstream regulated gene 1.